-
13501por Lin, Shih Ping, Wu, Chun-Ying, Wang, Chang-Bi, Li, Tsai-Chung, Ko, Nai-Ying, Shi, Zhi-Yuan“…Hypertension (sHR = 5.27; 95% CI, 3.21–8.65), gout (sHR = 2.39; 95% CI, 1.38–4.16), and hepatitis C virus (HCV) infection (sHR = 2.43; 95% CI, 1.28–4.61) were significantly associated with a higher risk of DM. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13502por Cazabon, Danielle, Pande, Tripti, Kik, Sandra, Van Gemert, Wayne, Sohn, Hojoon, Denkinger, Claudia, Qin, Zhi Zhen, Waning, Brenda, Pai, Madhukar“…In 2016, the median GeneXpert utilization was 20%, however seven countries (7/19; 37%) were running tests for other diseases on their NTP-procured GeneXpert systems in 2017, such as HIV, hepatitis-C virus (HCV), Chlamydia trachomatis, and Neisseria gonorrhoeae. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13503“…The World Health Organization HCV Guideline Development Group is considering a “treat all” recommendation for persons infected with hepatitis C virus (HCV). We reviewed the model-based evidence of cost-effectiveness and population health impacts comparing expanded treatment policies to more limited treatment access policies, focusing primarily on evaluations of all-oral directly acting antivirals published after 2012. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13504por Adejumo, Adeyinka Charles, Adegbala, Oluwole Muyiwa, Adejumo, Kelechi Lauretta, Bukong, Terence Ndonyi“…BACKGROUND AND AIM: The effect of cannabis use on chronic liver disease (CLD) from Hepatitis C Virus (HCV) infection, the most common cause of CLD, has been controversial. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13505por Real, Luis M., Macías, Juan, Pérez, Ana B., Merino, Dolores, Granados, Rafael, Morano, Luis, Delgado, Marcial, Ríos, María J., Galera, Carlos, Deltoro, Miguel G., Merchante, Nicolás, García, Federico, Pineda, Juan A.“…Hepatitis C virus (HCV) response to direct-acting antivirals (DAAs) may be influenced by the presence of resistance-associated substitutions (RASs). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13506por Sosa-Jurado, Francisca, Meléndez-Mena, Daniel, Rosas-Murrieta, Nora H., Guzmán-Flores, Belinda, Mendoza-Torres, Miguel A., Barcenas-Villalobos, Roberto, Márquez-Domínguez, Luis, Cortés-Hernández, Paulina, Reyes-Leyva, Julio, Vallejo-Ruiz, Verónica, Santos-López, Gerardo“…Primers were tested in serum samples of 45 patients not co-infected with hepatitis C virus or with HIV, out of a group of 116 HBsAg (-)/anti-HBc (+) individuals. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13507por Shigekawa, Yoshinobu, Hayami, Shinya, Ueno, Masaki, Miyamoto, Atsushi, Suzaki, Norihiko, Kawai, Manabu, Hirono, Seiko, Okada, Ken-ichi, Hamamoto, Ryuji, Yamaue, Hiroki“…KDM5B-positive group had much poorer prognosis than that of the negative group, especially in HCC derived from persistent infection of hepatitis B virus (HBV) or hepatitis C virus (HCV) (54% vs 78%, p=0.015). Multivariate analysis indicated that KDM5B was the strongest risk factor for poor prognosis, especially in HCC derived from HBV/HCV. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13508por Sims, Seth, Longmire, Atkinson G., Campo, David S., Ramachandran, Sumathi, Medrzycki, Magdalena, Ganova-Raeva, Lilia, Lin, Yulin, Sue, Amanda, Thai, Hong, Zelikovsky, Alexander, Khudyakov, Yury“…BACKGROUND: Molecular surveillance and outbreak investigation are important for elimination of hepatitis C virus (HCV) infection in the United States. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13509por Romero-López, Cristina, Ríos-Marco, Pablo, Berzal-Herranz, Beatriz, Berzal-Herranz, Alfredo“…The RNA genome of the hepatitis C virus (HCV) encodes a single open reading frame (ORF) containing numerous functional elements. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13510por Kanyaboon, Parichat, Saelee, Thanaphon, Suroengrit, Aphinya, Hengphasatporn, Kowit, Rungrotmongkol, Thanyada, Chavasiri, Warinthorn, Boonyasuppayakorn, Siwaporn“…A previous report suggested that anacardic acid inhibited hepatitis C virus infection. Here, we explored structure activity relationship of anacardic acid, cardanol, and cardol homologues with anti-DENV cellular infectivities. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13511“…Future plans include expanding testing to adolescents and utilizing similar methods to integrate Hepatitis C testing. DISCLOSURES: All Authors. Gilead Sciences, Inc.: Grant Investigator, Grant recipient and Salary.…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13512por Winetsky, Daniel, Slowikowski, Jacek, Zucker, Jason, Scherer, Matthew, Gordon, Peter“…BACKGROUND: Historically, hepatitis C virus (HCV) infection was most prevalent among those born between 1945 and 1965. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13513“…Predictors included history of hepatitis C virus (HCV; a flavivirus) by laboratories, dengue diagnosis, immunocompromising condition diagnosis, gender, age, and history of exposure to dengue endemic region (either through birth, travel, or residency). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13514“…In the current study, the diagnostic performance of serum AKR1B10 in hepatitis B virus/hepatitis C virus (HBV/HCV)-related liver disorders was evaluated and the unique role of AKR1B10 in diagnosing HCC was assessed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13515por Garcia-Broncano, Pilar, Medrano, Luz Maria, Berenguer, Juan, González-García, Juan, Jiménez-Sousa, Mª Ángeles, Carrero, Ana, Hontañón, Victor, Guardiola, Josep M., Crespo, Manuel, Quereda, Carmen, Sanz, José, García-Gómez, Ana Belen, Jimenez, Jose Luis, Resino, Salvador“…We aimed to evaluate the levels of peripheral CD4(+) T cells (Tregs) and plasma cytokine in patients coinfected with human immunodeficiency virus and hepatitis C virus (HIV/HCV) according to liver fibrosis stages [evaluated as liver stiffness measure (LSM)] and their linear relationship. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13516por Rau, Monika, Schmitt, Johannes, Berg, Thomas, Kremer, Andreas E., Stieger, Bruno, Spanaus, Katharina, Bengsch, Bertram, Romero, Marta R., Marin, Jose J., Keitel, Verena, Klinker, Hartwig, Tony, Hans-Peter, Müllhaupt, Beat, Geier, Andreas“…BACKGROUND & AIMS: Serum interferon-gamma-inducible protein-10 (IP-10) is elevated in cholestatic liver diseases and predicts response to antiviral therapy in patients with chronic hepatitis C virus (HCV) infection. Dipeptidylpeptidase 4 (DPPIV) cleaves active IP-10 into an inactive form, which inhibits recruitment of CXCR3+ T cells to the liver. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13517por Ramachandran, Sumathi, Thai, Hong, Forbi, Joseph C., Galang, Romeo Regi, Dimitrova, Zoya, Xia, Guo-liang, Lin, Yulin, Punkova, Lili T., Pontones, Pamela R., Gentry, Jessica, Blosser, Sara J., Lovchik, Judith, Switzer, William M., Teshale, Eyasu, Peters, Philip, Ward, John, Khudyakov, Yury“…BACKGROUND: A high prevalence (92.3%) of hepatitis C virus (HCV) co-infection among HIV patients identified during a large HIV outbreak associated with injection of oxymorphone in Indiana prompted genetic analysis of HCV strains. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13518por Hallager, Sofie, Lundh, Andreas, Ladelund, Steen, Gerstoft, Jan, Laursen, Alex Lund, Clausen, Mette Rye, Balslev, Ulla, Weis, Nina“…RESULTS: In total, 8490 patients were included: 3091 had chronic hepatitis B (CHB), 5305 had chronic hepatitis C (CHC), and 94 had CHB and CHC. The prevalence of HIV coinfection was 4.4% (95% confidence interval [CI], 4.0–4.9) and was higher among CHC and CHB-CHC patients than CHB patients with a prevalence of 5.3% (95% CI, 4.7–5.9), 6.4% (95% CI, 2.4–13.4), and 2.9 (95% CI, 2.3–3.5), respectively (P < .0001). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13519por Almueilo, Samir H.“…Gender, hemoglobin level, serum albumin, ferritin, parathyroid hormone level and hepatitis C virus infection had no effect on the response to the vaccine. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13520por Rostamzadeh, Masomeh, Afkhamzadeh, Abdorrahim, Afrooz, Sirus, Mohamadi, Kaveh, Rasouli, Mohammad Aziz“…The dentists’ KAP regarding hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV/AIDS were evaluated. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto